Dissecting Antibodies Induced by a Chimeric Yellow FeverâÂÂ"Dengue, Live-Attenuated, Tetravalent D...
Dissecting Antibodies Induced by a Chimeric Yellow FeverâÂÂ"Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals
About this item
Full title
Author / Creator
Publisher
US: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
US: Oxford University Press
More information
Scope and Contents
Contents
Abstract
Sanofi Pasteur has developed a chimeric yellow feverâÂÂ"dengue, live-attenuated, tetravalent dengue vaccine (CYD-TDV) that is currently approved for use in several countries. In clinical trials, CYD-TDV was efficacious at reducing laboratory-confirmed cases of dengue disease. Efficacy varied by dengue virus (DENV) serotype and prevacc...
Alternative Titles
Full title
Dissecting Antibodies Induced by a Chimeric Yellow FeverâÂÂ"Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_oup_primary_10_1093_infdis_jiw576
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_oup_primary_10_1093_infdis_jiw576
Other Identifiers
ISSN
0022-1899
E-ISSN
1537-6613
DOI
10.1093/infdis/jiw576
